Cargando…
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
Introduction: Previous research delivers strong indications that inflammatory activation leads to treatment resistance in a subgroup of patients with Major Depressive Disorder (MDD). Thus, tailored interventions are needed. The present study aimed to find potential biomarkers that may enable patient...
Autores principales: | Simon, Maria S., Burger, Bianka, Weidinger, Elif, Arteaga-Henríquez, Gara, Zill, Peter, Musil, Richard, Drexhage, Hemmo A., Müller, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504576/ https://www.ncbi.nlm.nih.gov/pubmed/34646168 http://dx.doi.org/10.3389/fpsyt.2021.615261 |
Ejemplares similares
-
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
por: Arteaga-Henríquez, Gara, et al.
Publicado: (2019) -
SERTRALINE INDUCED HYPOMANIA
por: Kumar, Ratanendra, et al.
Publicado: (2000) -
Hyperamylasemia Related to Sertraline
por: Ceylan, Mehmet Emin, et al.
Publicado: (2016) -
Sertraline-induced Hemichorea
por: Gatto, Emilia M., et al.
Publicado: (2017) -
Wide Spectrum of Inhibitory Effects of Sertraline on Cardiac Ion Channels
por: Lee, Hyang-Ae, et al.
Publicado: (2012)